Skip to content

Pricing Sign in

A bill for an act relating to price transparency for prescription drugs sold in this state, and including applicability provisions. (See HF 2551.)

This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.

IA HF 2253 · Hf · 2019-2020

Stage: Session ended
Sponsor: 1
Latest action: Feb 19, 2020

Where it stands

Introduced (Done)
Committee (Current step)
Reported from committee · Feb 19, 2020
Floor (Needs attention)
The session ended first
Law (Not started)

This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.

Read the full text

What moved

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

Shannon LundgrenLead sponsor

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money in Iowa.

Who sits in the seats that vote on itA roster is not a certified tally, and a filing is not a place on the ballot.
Who funds the people decidingA receipt is not backing. A contribution does not establish a policy motive.
Who is paid to be heardNaming an institution is the filer's account, not a record of any meeting.

Work with this bill

A bill for an act relating to price transparency for prescription drugs sold in this state, and including applicability provisions. (See HF 2551.) | 52